Literature DB >> 22435389

Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer.

Virendra Kumar1, Naranamangalam R Jagannathan, Sanjay Thulkar, Rajeev Kumar.   

Abstract

INTRODUCTION: Existing screening investigations for the diagnosis of early prostate cancer lack specificity, resulting in a high negative biopsy rate. There is increasing interest in the use of various magnetic resonance methods for improving the yield of transrectal ultrasound-guided biopsies of the prostate in men suspected to have prostate cancer. We review the existing status of such investigations.
METHODS: A literature search was carried out using the Pubmed database to identify articles related to magnetic resonance methods for diagnosing prostate cancer. References from these articles were also extracted and reviewed.
RESULTS: Recent studies have focused on prebiopsy magnetic resonance investigations using conventional magnetic resonance imaging, dynamic contrast enhanced magnetic resonance imaging, diffusion weighted magnetic resonance imaging, magnetization transfer imaging and magnetic resonance spectroscopy of the prostate. This marks a shift from the earlier strategy of carrying out postbiopsy magnetic resonance investigations. Prebiopsy magnetic resonance investigations has been useful in identifying patients who are more likely to have a biopsy positive for malignancy.
CONCLUSIONS: Prebiopsy magnetic resonance investigations has a potential role in increasing specificity of screening for early prostate cancer. It has a role in the targeting of biopsy sites, avoiding unnecessary biopsies and predicting the outcome of biopsies.
© 2012 The Japanese Urological Association.

Entities:  

Mesh:

Year:  2012        PMID: 22435389     DOI: 10.1111/j.1442-2042.2012.02995.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  10 in total

1.  Validating multiparametric MRI for diagnosis and monitoring of prostate cancer in patients for active surveillance.

Authors:  Iqbal Sahibzada; Deepak Batura; Giles Hellawell
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

Review 2.  Multiparametric MRI for prostate cancer diagnosis: current status and future directions.

Authors:  Armando Stabile; Francesco Giganti; Andrew B Rosenkrantz; Samir S Taneja; Geert Villeirs; Inderbir S Gill; Clare Allen; Mark Emberton; Caroline M Moore; Veeru Kasivisvanathan
Journal:  Nat Rev Urol       Date:  2019-07-17       Impact factor: 14.432

3.  Histotripsy focal ablation of implanted prostate tumor in an ACE-1 canine cancer model.

Authors:  George R Schade; Jill Keller; Kim Ives; Xu Cheng; Thomas J Rosol; Evan Keller; William W Roberts
Journal:  J Urol       Date:  2012-09-20       Impact factor: 7.450

4.  What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?

Authors:  Pieter Julien Luc De Visschere; Leslie Naesens; Louis Libbrecht; Charles Van Praet; Nicolaas Lumen; Valérie Fonteyne; Eva Pattyn; Geert Villeirs
Journal:  Eur Radiol       Date:  2015-07-03       Impact factor: 5.315

Review 5.  Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists.

Authors:  Sangjun Yoo; Jeong Kon Kim; In Gab Jeong
Journal:  Korean J Urol       Date:  2015-06-30

6.  Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens.

Authors:  Kosuke Kitamura; Satoru Muto; Isao Yokota; Kazutane Hoshimoto; Tatsuro Kaminaga; Takahiro Noguchi; Syou-Ichiro Sugiura; Hisamitsu Ide; Raizo Yamaguchi; Shigeru Furui; Shigeo Horie
Journal:  Prostate Int       Date:  2014-12-30

Review 7.  Role of multiparametric magnetic resonance imaging in early detection of prostate cancer.

Authors:  Pieter J L De Visschere; Alberto Briganti; Jurgen J Fütterer; Pirus Ghadjar; Hendrik Isbarn; Christophe Massard; Piet Ost; Prasanna Sooriakumaran; Cristian I Surcel; Massimo Valerio; Roderick C N van den Bergh; Guillaume Ploussard; Gianluca Giannarini; Geert M Villeirs
Journal:  Insights Imaging       Date:  2016-02-04

Review 8.  Is contrast enhancement needed for diagnostic prostate MRI?

Authors:  Michele Scialpi; Valeria Rondoni; Maria Cristina Aisa; Eugenio Martorana; Alfredo D'Andrea; Corrado Maria Malaspina; Agostino Orlandi; Giorgio Galassi; Emanuele Orlandi; Pietro Scialpi; Michele Dragone; Diego Palladino; Annalisa Simeone; Michele Amenta; Giampaolo Bianchi
Journal:  Transl Androl Urol       Date:  2017-06

9.  Transperineal ultrasound-guided prostate biopsy is safe even when patients are on combination antiplatelet and/or anticoagulation therapy.

Authors:  Kimitoshi Saito; Satoshi Washino; Yuhki Nakamura; Tsuzumi Konishi; Masashi Ohshima; Yoshiaki Arai; Tomoaki Miyagawa
Journal:  BMC Urol       Date:  2017-07-05       Impact factor: 2.264

10.  Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and 2 in a Cohort of 245 Patients with Histopathological Reference and Long-Term Follow-Up.

Authors:  Pieter De Visschere; Eva Pattyn; Piet Ost; Tom Claeys; Nicolaas Lumen; Geert Villeirs
Journal:  J Belg Soc Radiol       Date:  2016-11-24       Impact factor: 1.894

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.